Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium Tuberculosis Cell Envelope”

ACS Omega - United States
doi 10.1021/acsomega.7b01966
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Mycobacterium Tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

Bovine Tuberculosis: Badger-Cull Targets Unlikely to Reduce TB

Nature
Multidisciplinary
2015English

Classification of Drugs to Treat Multidrug-Resistant Tuberculosis (MDR-TB): Evidence and Perspectives

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Mycobacterium Tuberculosis Resistance to Antituberculosis Drugs in Mozambique

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2014English

Expedient Synthesis of a Linear Nonadecaarabinofuranoside of the Mycobacterium Tuberculosis Cellular Envelope

European Journal of Organic Chemistry
Organic ChemistryTheoretical ChemistryPhysical
2017English

Correction To: Characterization of Mycobacterium Tuberculosis Ferredoxin With Mössbauer Spectroscopy

Hyperfine Interactions
Condensed Matter PhysicsNuclearMolecular Physics,High Energy PhysicsTheoretical ChemistryAtomicOpticsPhysical
2020English

The T-Cell Response to Lipid Antigens of Mycobacterium Tuberculosis

Frontiers in Immunology
AllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy